*This is not financial advice, so trade at your own risks*
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals:
My team has been reviewing Mirum Pharmaceuticals for close to two months, and despite its poor performance in the past month it remains one of top picks for the month of June.
MIRM is to release data collected on maralixibat on 6/5/21.
Tomorrow morning we are averaging up on our positions at $17.00. Our original entry was at $16.30.
Short term take profit @$20.00 Long Term take profit $26.00
If you want to see more, please like and follow us @SimplyShowMeTheMoney
*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*
*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals:
My team has been reviewing Mirum Pharmaceuticals for close to two months, and despite its poor performance in the past month it remains one of top picks for the month of June.
MIRM is to release data collected on maralixibat on 6/5/21. Tomorrow morning we are averaging up on our positions at $17.00. Our original entry was at $16.30.
Short term take profit @$20.00 Long Term take profit $26.00
If you want to see more, please like and follow us @SimplyShowMeTheMoney
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。